Lanean...
Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal
For well over 30 years, the botulinum neurotoxin (BoNT) has been used for a large number of indications, some of which however have not been licensed. Admittedly, approval varies in many countries and this permits a large spectrum for evaluation. Thus, BoNT is used for patients with Parkinson’s dise...
Gorde:
| Argitaratua izan da: | Toxins (Basel) |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7910947/ https://ncbi.nlm.nih.gov/pubmed/33503872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins13020087 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|